US Stock MarketDetailed Quotes

Madrigal Pharmaceuticals (MDGL)

Watchlist
  • 568.570
  • -8.730-1.51%
Close Dec 8 16:00 ET
  • 568.570
  • 0.0000.00%
Post 18:16 ET
12.91BMarket Cap-44.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Madrigal Pharmaceuticals (MDGL) Key Financial Indicators

MDGL Earnings per Share (EPS)

According to the latest financial report of Madrigal Pharmaceuticals, the latest earnings per share (TTM) for the company is -5.08. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

MDGL Free Cash Flow (FCF)

Interested in knowing about Madrigal Pharmaceuticals's free cash flow? The latest report shows it as 75.99M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

MDGL Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Madrigal Pharmaceuticals shows that the company's current ratio is 3.44, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

MDGL Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Madrigal Pharmaceuticals, the quick ratio is 3.12, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

MDGL Return on Equity (ROE)

Want to learn more about the financial health of Madrigal Pharmaceuticals? The latest ROE figure is -17.28%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

MDGL Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Madrigal Pharmaceuticals, the total asset return on investment (ROA) is -9.60%.

Currency: USD

Quarterly

Loading...

MDGL Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Madrigal Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 93.69%.

Currency: USD

Quarterly

Loading...

MDGL Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Madrigal Pharmaceuticals, the net profit margin is -39.75%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.82%
Sample Name
Sample Code
 +5.66%
Sample Name
Sample Code
 +1.46%
4
BEKE-W
02423
+0.72%
5
TRIP.COM-S
09961
+0.09%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.41%
Sample Name
Sample Code
 +2.78%
Sample Name
Sample Code
 +2.21%
4
Interactive Brokers
IBKR
+2.03%
5
NVIDIA
NVDA
+1.72%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -